Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA through Type D interactions, and the Company believes its man ...

(NYSE: WT) (“WisdomTree”), a global financial innovator, today announced the pricing of its offering of $525.0 million aggregate principal amount of convertible senior notes due 2031 (the “notes”) in ...

Liberty Energy Inc. (NYSE: LBRT) (“Liberty”) today announced the pricing of, and that it has agreed to sell, $475.0 million ...

Jefferies, Evercore ISI, Citigroup and Guggenheim Securities are acting as joint-book running managers for the Convertible Notes Offering and Equity Offering. Wedbush PacGrow is acting as co-manager ...

The amendment to Section 15(3)(b) removes rigid conditions for post-supply discounts. It simplifies compliance but leaves key ...

We are already tracking toward record monthly production in early 2026, with February being our highest production month in company history." Duran explained, "Looking ahead into 2026, we are now ...

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...

Henkel (HENKY) remains a 'Buy' with a revised price target of €74/share, reflecting cautious optimism despite recent ...

The board of trustees (the "Board") of NXG NextGen Infrastructure Income Fund (NYSE: NXG) (the "Fund") has approved the terms of the issuance of transferable rights ("Rights") to the holders of the ...

NOTE: Some of these events may have been canceled or postponed. Please check with the organizers. Call 843-873-9424 to add an ...

Warren Buffett’s wealth-building strategy hinges on a rigorous four-point quality filter: high return on equity, high capital ...

At a General Meeting on 11 June 2025, shareholders approved the subdivision and redesignation of the Company’s Issued ...